Patients with ongoing depression despite apparently adequate treatment with standard drugs may benefit from treatment with ethyl-eicosapentaenoate, 1 gram per day. That’s according to study results published in the October Archives of General Psychiatry.
“We did this study because we and groups of investigators in the USA, Canada, Japan, Australia, and Belgium have all found that red blood cells and/or plasma in depressed patients often have abnormally low levels of eicosapentaenoate,” Dr. David F. Horrobin told Reuters Health. “Since eicosapentaenoate is an important molecule, which helps to determine how nerve cells behave, this deficit could play an important role in depression,” he added.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!